Article ; Online: Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry.
2020 Volume 15, Issue 1, Page(s) 32
Abstract: ... of OAT according to age and thromboembolic risk in patients included in CARMEN-AF, a nationwide registry ... patients ≥18 years old and with at least one thromboembolic risk factor enrolled in the CARMEN-AF Registry ... CARMEN-AF is a nationwide multi-centric registry seeking to bridge the data gap on anticoagulation ...
Abstract | Background: Documenting the patterns of oral anticoagulation therapy (OAT) is essential to prevent thromboembolic complications of nonvalvular atrial fibrillation (NVAF). Objective: To report the patterns of OAT according to age and thromboembolic risk in patients included in CARMEN-AF, a nationwide registry of NVAF in Mexico, an upper middle-income country. Material and methods: There were 1,423 consecutive patients ≥18 years old and with at least one thromboembolic risk factor enrolled in the CARMEN-AF Registry at their regular clinical visit during a three-year period. They were analyzed according to 1) age, 2) AF type, and 3) CHA Results: Overall, 16.4% of patients did not receive antithrombotic treatment, 19.4% received antiplatelet drugs (APD), 29.2% vitamin K antagonists (VKA), and 34.6% direct oral anticoagulants (DOAC). With increasing age, the proportion of subjects treated with VKA decreased significantly from 36.2% in subjects <65 years to 22.5% in those ≥75 years old ( Conclusions: VKA use for NVAF in Mexico decreased in relation to increasing age. The proportion of DOAC therapy was the same in all age groups. Nevertheless, elderly patients with high thromboembolic risk received a suboptimal thromboprophylaxis. These data could help to improve gaps in the implementation of global guidelines. Clinical trial registration: http://www.clinicaltrials.gov. Unique identifier: NCT02334852. Highlights: CARMEN-AF is a nationwide multi-centric registry seeking to bridge the data gap on anticoagulation therapy for NVAF in Mexico.Elderly patients are more prone to receive suboptimal OAT for NVAF.DOAC were less frequently used in high thromboembolic risk patients (CHA |
---|---|
MeSH term(s) | Age Factors ; Aged ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Female ; Fibrinolytic Agents/therapeutic use ; Humans ; Incidence ; Male ; Mexico/epidemiology ; Registries ; Risk Factors ; Stroke/epidemiology ; Stroke/etiology ; Stroke/prevention & control ; Survival Rate/trends ; Thromboembolism/complications ; Thromboembolism/prevention & control |
Chemical Substances | Fibrinolytic Agents |
Language | English |
Publishing date | 2020-04-10 |
Publishing country | England |
Document type | Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2629633-0 |
ISSN | 2211-8179 ; 2211-8160 |
ISSN (online) | 2211-8179 |
ISSN | 2211-8160 |
DOI | 10.5334/gh.767 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.